Chad leads the Healthcare Practice at Woodruff Sawyer and has a deep understanding of the complex risks facing these entities today. He delivers optimal risk management solutions to protect their assets, people and reputations. His expertise in the healthcare and medical industry includes regulatory risk, data privacy and cyber risks, alternative risk finance structures (captives, RRGs, SIRs and trusts) and risk solutions for ACOs and all forms of coordinate care structures.
Chad is a Risk & Insurance Magazine “Power Broker” award recipient and a member of, and frequent presenter at, leading industry associations including ASHRM, CAHF and HFMA. He authors blog features on timely healthcare topics.
Chad earned his bachelor’s degree in risk management at the University of Georgia, received his MBA from Wake Forest University, and completed the Executive Education course on Exotic Risk Management at the Wharton School.
The Life Sciences M&A market shows no sign of slowing down. The 2018 total value of life sciences M&A should once again surpass $200 billion. The lull in biopharma deal-making last year and the passage of US tax reform increase both desire and need for growth by acquisition, via M&A.